SponsoredReduce Risk Of End-Stage Kidney Disease In Your CKD in T2D Patients With A Treatment. Reduce The Risk Of Sustained eGFR Decline In CKD in T2D Patients With A Once-Daily Pill.
Types: Downloadable Resources, Case Study Videos, Clinical Trial Data
SponsoredUnlock Top Investing Ideas with Seeking Alpha's Trusted Market Research and Analysis. Get Exclusive Access to Stock Picks, Market Trends, and Premium Investment Content.
$4.95 Your First Month · Alpha Picks · Compare Your Stocks